Medip
Medip - Related Videos
10:21
An Overview of Epigenetics
0 Views •
2023
Since the early days of genetics research, scientists have noted certain heritable phenotypic differences that are not due to differences in the nucleotide sequence of DNA. Current evidence suggests that these “epigenetic” phenomena might be controlled by a number of mechanisms, including the modification of DNA cytosine bases with methyl groups, the addition of various chemical groups to histone proteins, and the recruitment of protein factors to specific DNA sites via interactions with...
08:47
DNA Methylation Analysis
0 Views •
2023
Methylation at CpG dinucleotides is a chemical modification of DNA hypothesized to play important roles in regulating gene expression. In particular, the methylation of clusters of methylation sites, called “CpG islands”, near promoters and other gene regulatory elements may contribute to the stable silencing of genes, for example, during epigenetic processes such as genomic imprinting and X-chromosome inactivation. At the same time, aberrant CpG methylation has been shown to be associated with...
FAQs
The antibody supplies the method’s molecular selectivity by recognizing 5-methylcytosine within fragmented genomic DNA. DNA fragments carrying this methylated cytosine are separated through immunoprecipitation from fragments that lack the recognized modification. This enrichment allows subsequent analysis to focus on genomic regions associated with DNA methylation rather than treating all recovered DNA fragments as equivalent.
Fragmentation divides genomic DNA into pieces that can be exposed efficiently to the antibody and then separated during immunoprecipitation. The resulting enriched fragments represent methylated regions that can be mapped across the genome. This organization supports analysis of where methylation occurs, including regions connected with promoters, gene regulation, imprinting, development, or disease-associated changes.
MeDIP can help connect methylation patterns with biological regulation and cellular states. In genetics and epigenetics, researchers can examine whether methylated regions occur near promoters, how they relate to gene regulation, and how patterns differ in contexts involving genomic imprinting, cellular identity, development, or disease mechanisms. The method therefore links a DNA modification with broader biological processes.
A basic workflow begins with genomic DNA, which is fragmented before exposure to an antibody recognizing 5-methylcytosine. Immunoprecipitation then separates antibody-associated methylated fragments from the other DNA fragments. The enriched material is subsequently analyzed by sequencing or microarray, producing data that can be used to map methylated regions across the genome.
Both sequencing and microarray analysis provide ways to examine the DNA enriched during immunoprecipitation. They allow researchers to assess the genomic distribution of methylated fragments and identify methylated regions for further interpretation. Using these readouts, investigators can study promoter methylation, gene regulation, imprinting, and disease-associated changes in DNA methylation.
Researchers may apply MeDIP when they need to investigate genome-wide patterns of methylated DNA in relation to genetic or epigenetic questions. Its applications include examining promoter methylation, gene regulation, genomic imprinting, and methylation changes associated with disease. These analyses can help relate epigenetic patterns to cellular identity, development, and mechanisms underlying disease.
Mapping methylated regions can provide evidence for relationships between epigenetic modification and changes in cellular identity, development, or disease mechanisms. It can also reveal methylation patterns relevant to promoter activity, gene regulation, and genomic imprinting. MeDIP therefore contributes contextual information about how methylated DNA patterns may be associated with biological states or processes.